743 related articles for article (PubMed ID: 12746916)
21. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia.
Moshiree B; Price DD; Robinson ME; Gaible R; Verne GN
Clin J Pain; 2007 May; 23(4):323-30. PubMed ID: 17449993
[TBL] [Abstract][Full Text] [Related]
22. Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and Fibromyalgia Syndrome.
Pfau DB; Rolke R; Nickel R; Treede RD; Daublaender M
Pain; 2009 Dec; 147(1-3):72-83. PubMed ID: 19767146
[TBL] [Abstract][Full Text] [Related]
23. Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.
Henriksen M; Lund H; Christensen R; Jespersen A; Dreyer L; Bennett RM; Danneskiold-Samsøe B; Bliddal H
Arthritis Rheum; 2009 Jun; 61(6):732-9. PubMed ID: 19479709
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes.
Sethna NF; Meier PM; Zurakowski D; Berde CB
Pain; 2007 Sep; 131(1-2):153-61. PubMed ID: 17329025
[TBL] [Abstract][Full Text] [Related]
25. Differences and similarities between atypical facial pain and trigeminal neuropathic pain.
Forssell H; Tenovuo O; Silvoniemi P; Jääskeläinen SK
Neurology; 2007 Oct; 69(14):1451-9. PubMed ID: 17909158
[TBL] [Abstract][Full Text] [Related]
26. Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing.
Kelly KG; Cook T; Backonja MM
Muscle Nerve; 2005 Aug; 32(2):179-84. PubMed ID: 15937874
[TBL] [Abstract][Full Text] [Related]
27. Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia.
Blumenstiel K; Gerhardt A; Rolke R; Bieber C; Tesarz J; Friederich HC; Eich W; Treede RD
Clin J Pain; 2011 Oct; 27(8):682-90. PubMed ID: 21487289
[TBL] [Abstract][Full Text] [Related]
28. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
[TBL] [Abstract][Full Text] [Related]
29. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms.
Wolfe F; Ross K; Anderson J; Russell IJ
J Rheumatol; 1995 Jan; 22(1):151-6. PubMed ID: 7699662
[TBL] [Abstract][Full Text] [Related]
30. Evidence of spinal cord hyperexcitability as measured with nociceptive flexion reflex (NFR) threshold in chronic lateral epicondylalgia with or without a positive neurodynamic test.
Lim EC; Sterling M; Pedler A; Coombes BK; Vicenzino B
J Pain; 2012 Jul; 13(7):676-84. PubMed ID: 22687426
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous silent period in fibromyalgia.
Sahin O; Yildiz S; Yildiz N
Neurol Res; 2011 May; 33(4):339-43. PubMed ID: 21535931
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in nociceptive withdrawal reflex and pain perception.
Mylius V; Kunz M; Schepelmann K; Lautenbacher S
Somatosens Mot Res; 2005 Sep; 22(3):207-11. PubMed ID: 16338828
[TBL] [Abstract][Full Text] [Related]
33. Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia.
Valim V; Oliveira LM; Suda AL; Silva LE; Faro M; Neto TL; Feldman D; Natour J
J Rheumatol; 2002 Feb; 29(2):353-7. PubMed ID: 11842825
[TBL] [Abstract][Full Text] [Related]
34. Pressure pain thresholds of tender point sites in patients with fibromyalgia and in healthy controls.
Maquet D; Croisier JL; Demoulin C; Crielaard JM
Eur J Pain; 2004 Apr; 8(2):111-7. PubMed ID: 14987620
[TBL] [Abstract][Full Text] [Related]
35. Quantitative sensory testing: a comprehensive protocol for clinical trials.
Rolke R; Magerl W; Campbell KA; Schalber C; Caspari S; Birklein F; Treede RD
Eur J Pain; 2006 Jan; 10(1):77-88. PubMed ID: 16291301
[TBL] [Abstract][Full Text] [Related]
36. C2 area neurostimulation: a surgical treatment for fibromyalgia.
Thimineur M; De Ridder D
Pain Med; 2007; 8(8):639-46. PubMed ID: 18028042
[TBL] [Abstract][Full Text] [Related]
37. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
Wolfe F; Michaud K
J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
[TBL] [Abstract][Full Text] [Related]
38. Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia.
Montoya P; Sitges C; García-Herrera M; Izquierdo R; Truyols M; Blay N; Collado D
Psychosom Med; 2005; 67(6):957-63. PubMed ID: 16314601
[TBL] [Abstract][Full Text] [Related]
39. Ethnocultural and educational differences in Israeli women correlate with pain perception in fibromyalgia.
Neumann L; Buskila D
J Rheumatol; 1998 Jul; 25(7):1369-73. PubMed ID: 9676771
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness of fibromyalgia clinical trial outcome measures.
Dunkl PR; Taylor AG; McConnell GG; Alfano AP; Conaway MR
J Rheumatol; 2000 Nov; 27(11):2683-91. PubMed ID: 11093454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
